Form 4: ANAPTYSBIO Director J. Anthony Ware Converts Restricted Stock Units to Common Shares

ANAPTYSBIO, Inc. Director J. Anthony Ware converted 6,030 restricted stock units into common shares on June 15, 2025, increasing his direct beneficial ownership to 13,530 shares.

Summary

• J. Anthony Ware, a Director of ANAPTYSBIO, INC. (ANAB), reported a transaction on June 15, 2025.
• The transaction involved the exercise/maturity ('M' code) of 6,030 Restricted Stock Units (RSUs) into shares of Common Stock.
• The acquisition price for these shares was $0, as they represent the conversion of previously granted RSUs.
• Following this transaction, J. Anthony Ware directly beneficially owns 13,530 shares of ANAPTYSBIO Common Stock.
• Each RSU represents a contingent right to receive one share of the Issuer's Common Stock for no consideration.
• The RSUs vested 100% on the date of the Issuer's 2025 annual meeting of shareholders, contingent on Mr. Ware's continued service to the Issuer.

Sentiment

Score: 6

Explanation: The conversion of Restricted Stock Units (RSUs) into common stock by a director is a routine compensation event. While not indicative of new investment, it increases the director's direct stake, which is generally viewed as a positive alignment of interests.

Positives

• Director J. Anthony Ware increased his direct beneficial ownership of ANAPTYSBIO, INC. common stock by 6,030 shares, demonstrating continued alignment with shareholder interests.

Future Outlook

The Restricted Stock Units (RSUs) vested 100% on the date of the Issuer's 2025 annual meeting of shareholders, contingent on the Reporting Person's continued provision of service to the Issuer.

Industry Context

This Form 4 filing reports a standard insider transaction involving the conversion of restricted stock units (RSUs) into common shares, which is a common compensation practice in the biotechnology and pharmaceutical industries to align executive and director interests with long-term company performance. It does not provide specific insights into broader industry trends or competitive positioning.

Related Party Transactions

• The transaction involves the conversion of Restricted Stock Units (RSUs) granted to Director J. Anthony Ware into common stock, representing a form of equity compensation.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director may be seen as a positive signal of alignment of interests.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

Recommendation

Keywords

ANAPTYSBIO, ANAB, Form 4, SEC filing, insider transaction, director, stock ownership, restricted stock units, RSU conversion, equity compensation